Completed
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
NCT00105235
- Conditions
- Behavior, Digestive System Diseases, Liver Disease, +4 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Colorado Denver, Colorado, United States
- University of Miami School of Medicine Miami, Florida, United States
- University of Michigan Ann Arbor, Michigan, United States